• BRCA1 Mutation

    • Average 65% lifetime risk for breast cancer
    • 40-60% lifetime risk for second breast cancer (not reappearance of first tumor)
    • Average 39% lifetime risk for ovarian cancer
    • Increased risk for other cancer types, such as prostate cancer
  • BRCA2 Mutation

    • Average 45% lifetime risk for breast cancer (in females)
    • 6% lifetime risk for breast cancer (in males)
    • Average 11% lifetime risk for ovarian cancer
    • Increased risk for other cancer types, such as pancreatic, prostate, laryngeal, stomach cancer, and melanoma

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Other Clinics

Expert care in a location convenient for you. Visit one of our clinics to make an appointment.